Search

Your search keyword '"van Eerde, Albertien"' showing total 287 results

Search Constraints

Start Over You searched for: Author "van Eerde, Albertien" Remove constraint Author: "van Eerde, Albertien"
287 results on '"van Eerde, Albertien"'

Search Results

1. Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations

3. Hypomagnesaemia with varying degrees of extrarenal symptoms as a consequence of heterozygous CNNM2 variants

5. KidneyNetwork: using kidney-derived gene expression data to predict and prioritize novel genes involved in kidney disease

7. Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and Chromosome 17q12 Microdeletions

8. Menke-Hennekam syndrome; delineation of domain-specific subtypes with distinct clinical and DNA methylation profiles

9. Reassuring pregnancy outcomes in women with mild COL4A3-5–related disease (Alport syndrome) and genetic type of disease can aid personalized counseling

11. Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease

12. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

13. Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

14. Biallelic pathogenic variants in roundabout guidance receptor 1 associate with syndromic congenital anomalies of the kidney and urinary tract

15. Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.

16. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

18. Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease

19. Reassuring pregnancy outcomes in women with mild COL4A3-5 related disease (Alport Syndrome) as the genetic type of disease can aid personalized counseling.

20. Adult patient diagnosed with Muckle-Wells syndrome, antiphospholipid syndrome and glomerular haematuria

21. GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status update

22. Hypomagnesaemia with varying degrees of extrarenal symptoms as a consequence of heterozygous CNNM2 variants

23. The Role of Genetic Testing in Adult CKD

25. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria(European Journal of Human Genetics, (2021), 29, 8, (1186-1197), 10.1038/s41431-021-00858-1)

26. The Role of Genetic Testing in Adult CKD

28. Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data

29. Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease

30. Novel MUC1 variant identified by massively parallel sequencing explains interstitial kidney disease in a large Dutch family

32. De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms

33. Clinical and genetic analyses of a Dutch cohort of 40 patients with a nephronophthisis-related ciliopathy

34. Prioritization and burden analysis of rare variants in 208 candidate genes suggest they do not play a major role in CAKUT

35. Defects in t6A tRNA modification due to GON7 and YRDC mutations lead to Galloway-Mowat syndrome

36. Identification of human D lactate dehydrogenase deficiency

37. Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data

38. Novel MUC1 variant identified by massively parallel sequencing explains interstitial kidney disease in a large Dutch family

39. A questionnaire survey of radiological diagnosis and management of renal dysplasia in children

40. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

43. Mutations of the SLIT2–ROBO2 pathway genes SLIT2 and SRGAP1 confer risk for congenital anomalies of the kidney and urinary tract

44. MO047: Biallelic pathogenic variants in ROBO1 associate with syndromic CAKUT

45. MO034: Novel MUC1 variant identified by massively parallel sequencing explains interstitial kidney disease in a large Dutch family

46. FC044: Heterozygous Variants in Kinase Domain of NEK8 cause an Autosomal-Dominant Ciliopathy

47. Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

48. FC044: Heterozygous Variants in Kinase Domain of NEK8 cause an Autosomal-Dominant Ciliopathy

49. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease:Consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

50. Review of genetic testing in kidney disease patients: Diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups

Catalog

Books, media, physical & digital resources